Table I.
Clinical characteristics of the study population.
| Group | ||||
|---|---|---|---|---|
| Characteristics | All patients (n=56) | CTX (n=36) | FK506 (n=20) | P-value (CTX vs. FK506) |
| Sex, ratio (male/female) | 1.8 (36/20) | 2.0 (24/12) | 1.5 (12/8) | – |
| Age (years) | 46.9±13.62 | 48.6±10.29 | 43.2±17.21 | 0.22 |
| Proteinuria (g/24 h) | 6.40±3.65 | 6.02±3.54 | 7.13±3.83 | 0.28 |
| Serum albumin (g/l) | 24.21±6.08 | 25.31±6.11 | 22.24±5.64 | 0.07 |
| eGFR (ml/min/1.73 m2) | 113.33±36.35 | 112.72±29.35 | 114.44±47.28 | 0.88 |
| TC (mmol/l) | 9.43±6.82 | 8.17±2.49 | 11.70±10.72 | 0.16 |
| SBP (mmHg) | 133.5±16.98 | 131.4±17.65 | 132.4±12.65 | 0.79 |
| DBP (mmHg) | 81.3±12.05 | 81.8±13.22 | 80.2±9.40 | 0.51 |
| PLA2R antibody level (mU/ml) | 1.25±0.72 | 1.35±0.66 | 1.06±0.79 | 0.17 |
| AR antibody level (mU/ml) | 16.88±14.10 | 16.15±12.77 | 18.34±16.79 | 0.65 |
| SOD2 antibody level (mU/ml) | 3.73±6.15 | 2.87±5.78 | 5.27±6.65 | 0.19 |
eGFR, estimated glomerular filtration rate; TC, T-cell; SBP, systolic blood pressure; DBP, diastolic blood pressure; PLA2R, M-type phospholipase A2 receptor; AR, aldose reductase; SOD2, superoxide dismutase.